Building on the success of our inaugural event, ACI is excited to bring our 2nd Annual Life Sciences IP Due Diligence summit to the world’s number one life sciences hub, Boston! This event is a one-of-a-kind, interactive forum where top diligence experts will discuss best practices and strategies for executing a proper IP due diligence analysis, both for your own portfolio, and that of potential targets.


ACI’s Life Sciences IP Due Diligence Summit is the gathering place for IP and corporate counsel as well as business development executives to learn best practices to map out and conduct a successful and cost-effective due diligence analysis.


Fireside Chat on Global Factors Influencing IP Due Diligence with:

Philip S. Johnson
Former Senior VP of IP Policy and Strategy
Johnson & Johnson Law Department

Honorable Paul R. Michel (Ret.)
Former Chief Judge
United States Court of Appeals for the Federal Circuit


Esteemed Co-Chairs:

Drew Holmes, Ph.D.
Senior Patent Attorney
Novartis Pharmaceuticals Corp.

Donna Meuth
Associate General
Counsel IP
Eisai Inc.

Jennifer Zarutskie Sieczkiewicz
VP, Chief IP Counsel
Wave Life Sciences

Confirmed speakers include representatives from the following companies:

  • BonWrx Ltd.
  • Charles River Associates
  • Eisai Inc.
  • Foghorn Therapeutics
  • Forma Therapeutics
  • Genentech, Inc.
  • Houlihan Lokey
  • Jounce Therapeutics
  • KSQ Therapeutics
  • Merck & Co. Inc.
  • Novartis Institutes for
  • Biomedical Research
  • Novartis Pharmaceuticals Corp.
  • Pieris Pharmaceuticals, Inc.
  • Roivant Sciences, Inc.
  • Transformative Legal
  • University of California, Office of the President
  • VBI Vaccines Inc.
  • Wave Life Sciences


View Full Speakers List

Featured sessions for this year include:

  • Exploring the Worldwide IP Landscape: Fireside Chat on Global Factors Influencing Due Diligence with:
    Philip S. Johnson
    Former Senior VP of IP Policy & Strategy
    Johnson & Johnson Law Department
    Johnson-IP Strategy & Policy Consulting (New Hope, PA)
    Interviewed by:
    Honorable Paul R. Michel (Ret.)
    Former Chief Judge
    United States Court of Appeals for the Federal Circuit (Alexandria, VA)
  • Be in the Room Where it Happens – Here is your chance to be a part of the “dueling” deal teams as our team leaders walk you through a mock deal scenario providing best practices for fostering inter- and intra-team communications, and tailored solutions for overcoming top challenges faced by both acquirers and targets. Be prepared for this highly interactive think tank where everyone participates!
  • Fireside Chat with Lacy Kolo, PhD, Director of Tech IP and Advisory Practice at Houlihan Lokey
  • Money Talks: Venture Capitalist Spotlight with: Ralph Carmichael, Esq., Chairman and CEO at Bōnwrx Ltd

View Complete Agenda

Don’t miss this opportunity to benchmark your IP diligence strategies with top industry representatives. Register now and enjoy early bird savings!


Register Now

Hear what past participants have to say about this one-of-a-kind event:


“Unique high level sessions, good mix of in-house and outside counsel”

“Hearing from professionals involved in due diligence on a daily basis was very informative.”

“Great panels, lots of diversity of practice, and lots of seasoned practitioners”

“The design of the event brought us all together along with room intimacy”

“High quality and level of conversations”

“Awesome- Interactive and thorough information”

“Good focused discussions covering all aspects”




You may also be interested in:

Paragraph IV Disputes
Meet and network with the key influencers shaping the law, policy and proceedings of Hatch-Waxman litigation.

April 29-30, 2019
New York, NY

Event Contacts

For sponsorship opportunities please contact:
Esther Fleischhacker
Tel: 212-352-3220 ext. 5232
[email protected]

For media partnership opportunities please contact:
Linda Lam
Tel: 212-352-3220 ext. 5538
[email protected]

For questions about this year’s program/content, or information on how you can speak next year please contact:
Lisa Piccolo
Tel: 212-352-3220 ext. 5229
[email protected]